Morningstar Says SpaceX Could Be Worth Less Than Half Its $1.75 Trillion IPO Price

SpaceX’s IPO is being challenged on valuation, with Morningstar suggesting it could be worth less than half of its roughly $2.44 trillion market value on fundamentals. The article emphasizes that the company lacks profitability, EBITDA, margins, and dividends to support the price, despite strong launch dominance, a large Starlink footprint, and AI-related expansion through xAI. The piece is largely a cautionary valuation debate rather than a catalyst-driven market event.

Analysis

The key market dynamic is not whether the business is good, but whether the float is price-insensitive enough to absorb a valuation that leaves almost no room for execution error. When a newly listed name starts life at a multiple that implies perfection, the first few earnings cycles become a de facto duration test: any slowdown in Starlink or launch monetization will matter more than headline growth. That makes this less a “fundamentals vs narrative” debate than a reflexivity trade, where early holders’ profit-taking can create a vacuum if incremental buyers are benchmarked to private-market marks rather than public comps.

The more interesting second-order effect is that the market is likely to re-rate adjacent public beneficiaries rather than the IPO itself. RTX is the cleaner way to express aerospace exposure because it monetizes secular defense demand with cash yield and visible backlog, while also offering a valuation anchor that the new listing lacks. If capital rotates from speculative growth into cash-generative defense/infrastructure, contractors with pricing power and replacement demand should see multiple support even if the broader IPO proves volatile.

The contrarian miss is that skepticism may be directionally right but temporally wrong. A high-quality monopoly-like platform can stay expensive for a long time if it keeps compounding into adjacent markets, especially AI compute and connectivity, where TAM estimates are still underdeveloped. The near-term risk is not fundamental collapse but a drawdown from supply overhang and narrative fatigue over the next 1-3 months; the longer-term upside case requires evidence that non-launch revenue can scale faster than capex intensity, otherwise the valuation gap will persist for years.

Key Decisions for Investors

• Avoid chasing the IPO in the first 4-8 weeks; if a position is needed, wait for post-lockup/first-earnings volatility and only consider entry on a 25-35% drawdown from initial trading levels.
• Relative value: long RTX / short SPCX exposure via options or paired equity if borrow exists; RTX offers cash flow, backlog visibility, and dividend support versus a zero-anchored multiple in the new issue.
• For event-driven traders, buy downside protection on SPCX into the first two quarterly print windows after listing; implied vol should underprice the risk of a guidance miss or secondary selling pressure.
• If wanting to own the secular theme, prefer a basket approach: long RTX and other defense/infrastructure cash generators, while treating SPCX as a call option only after proof of margin expansion and sustained free cash flow.
• Set a catalyst trigger: if SPCX reports two consecutive quarters of accelerating revenue with improving margins, reassess; absent that, assume valuation compression continues over a 6-12 month horizon.